2026 Trend Report
Reducing Avoidable Protocol Amendments by Anticipating Operational Pitfalls Hidden in Clinical Trial Design
Protocol amendments are a costly but common part of clinical trials, often reflecting gaps between scientific ambition and real-world execution.
News
New Framework Proposes Risk-Based Governance for AI in Clinical Development
Estimated reading time: 4 minutes First deliverable from the Council for Responsible Use of...
Advarra to Showcase Technology Innovations for Research Sites at Onsemble 2026
Columbia, MD – April 2, 2026 – Advarra, the industry leader in integrated solutions...
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model
Blogs
Does mRNA Require IBC Review? How the NIH Guidelines Apply to Clinical Trials
Let me start with a question I get more and more frequently from research...
Sponsor’s Guide to IRB Approval (Part III): Building an IRB-Ready Informed Consent
Sponsor’s Guide to IRB Approval (Part III): Building an IRB-Ready Informed Consent For sponsors,...
A More Connected Approach to Clinical Trials: Reducing Friction from Study Design Through Conduct
Clinical trials are complex. That’s expected, given accelerated advancements in science and technology. But...
Sponsor’s Guide to IRB Approval (Part II): How to Draft a Clinical Trial Protocol That Stands Up to IRB Scrutiny
A strong clinical trial protocol does more than describe how a study will run....
Webinars
Embedding AI And Critical IRB Operations Data To Drive Intelligent Study Design
Enabling Oncology Site Success: Overcoming Administrative and Operational Barriers to Advance Cancer Research
Enabling Oncology Site Success: Overcoming Administrative and Operational Barriers to Advance Cancer Research Oncology...
Current State of Site-Sponsor-CRO Collaboration
Balancing Innovation, Ethics, and Operational Excellence in Adaptive Oncology Trials
Balancing Innovation, Ethics, and Operational Excellence in Adaptive Oncology Trials Clinical trials are evolving...